BCAL Diagnostics LimitedASX: BDX

BCAL Early Cancer Detection Tests Update

· Issued by BCAL Diagnostics Limited

Filed with ASX · · 4 pages · English

BCAL Chief Executive Officer Shane Ryan said: “Our partnership with ClearNote Health is transformative as it expands our portfolio into the early detection of multiple cancers. The Australian medical community will benefit from a suite of early diagnostic tests that will materially improve outcomes for patients. “ClearNote’s recent global achievements, including UK regulatory approval, selection f

BCAL Diagnostics Limited on 6ix

Story so far

Earlier from BCAL Diagnostics

Later from BCAL Diagnostics

All BCAL Diagnostics news releases